Gate Neurosciences

Carmel, United States

Gate Neurosciences is a healthcare company that offers neuroscience-related medical services.

$25.0M raised

Oct 2022

Venture - Series Unknown

Biotechnology Life Science Medical Neuroscience Pharmaceutical

Top Investors

BioCrossroads Innoviva Thornapple River Capital Luson Bioventures

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Gate Neurosciences

How much funding has Gate Neurosciences raised?

Gate Neurosciences has raised $25.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in October 2022.

Who are Gate Neurosciences's investors?

Gate Neurosciences's investors include BioCrossroads, Innoviva, Thornapple River Capital, Luson Bioventures.

Where is Gate Neurosciences headquartered?

Gate Neurosciences is headquartered in Carmel, United States.

What does Gate Neurosciences do?

Gate Neurosciences is a healthcare company that offers neuroscience-related medical services.

What stage is Gate Neurosciences at?

Gate Neurosciences is at the Venture - Series Unknown stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated October 5, 2022.

MLA

"Gate Neurosciences — Funding & Investors." VCBacked, October 5, 2022, https://www.vcbacked.co/company/gate-neurosciences. Accessed July 2, 2026.

APA

VCBacked. (2022). Gate Neurosciences — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/gate-neurosciences

Wikipedia (cite web)

{{cite web |title=Gate Neurosciences — Funding & Investors |url=https://www.vcbacked.co/company/gate-neurosciences |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated October 5, 2022.